US 12,344,592 B2
Methods, processes and intermediates for preparing chroman compounds
Rajender Kumar Kamboj, Pune Maharashtra (IN); Kamlesh Jyotindra Padiya, Pune Maharashtra (IN); Kamalakannan Prabakaran, Pune Maharashtra (IN); Kumar Ram Naik, Pune Maharashtra (IN); Bhavani Shankar Rajesh, Pune Maharashtra (IN); Ganpati Powar Rajendra, Pune Maharashtra (IN); Subhash Ingawale Sachin, Pune Maharashtra (IN); Dattatray Karche Amit, Pune Maharashtra (IN); Shankar Dange Santoshkumar, Pune Maharashtra (IN); and Barve Sitaram Rambhau, Pune Maharashtra (IN)
Assigned to LUPIN LIMITED, Maharastra (IN)
Appl. No. 17/792,298
Filed by Lupin Limited, Maharastra (IN)
PCT Filed Jan. 17, 2021, PCT No. PCT/IN2021/050045
§ 371(c)(1), (2) Date Jul. 12, 2022,
PCT Pub. No. WO2021/144814, PCT Pub. Date Jul. 22, 2021.
Claims priority of application No. 202021002110 (IN), filed on Jan. 17, 2020.
Prior Publication US 2023/0140054 A1, May 4, 2023
Int. Cl. C07D 311/58 (2006.01)
CPC C07D 311/58 (2013.01) 15 Claims
 
1. A method for the manufacture of 2-methyl-5-((2R,4S)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)benzoic acid (Compound A″) from methyl-5-((R)-2-(((tert-butoxycarbonyl)((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)-2H-chromen-4-yl)-2-methylbenzoate (Compound 10), wherein the method comprising:
a. converting methyl-5-((R)-2-(((tert-butoxycarbonyl)((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)-2H-chromen-4-yl)-2-methylbenzoate (Compound 10) to methyl 5-((2R)-2-(((tert-butoxycarbonyl)((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)-2-methylbenzoate (Compound 11), wherein the conversion is carried out through hydrogenation using palladium charcoal catalyst in methanolic ammonia under optimum hydrogen pressure not more than about 2.0 Kg/cm2, or through treatment with ammonium formate in the presence of a palladium charcoal catalyst, in the presence of one or more polar solvents, wherein the one or more polar solvents is selected from methanol, ethanol, propanol, ethyl acetate, tetrahydrofuran, dioxane, and a combination thereof,

OG Complex Work Unit Chemistry
b. converting Compound 11 to methyl 2-methyl-5-((2R)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl) chroman-4-yl)benzoate hydrochloride (Compound 12) through Boc-deprotection reaction using aqueous hydrochloric acid, trifluoroacetic acid or trimethyl silyl iodide in the presence of one or more polar solvents, wherein the one or more polar solvents is selected from methanol, dichloromethane, ethanol, propanol, ethyl acetate, tetrahydrofuran, dioxane, rand a combination thereof,

OG Complex Work Unit Chemistry
 and
c. hydrolyzing the ester group of Compound 12 using one or more hydroxide bases followed by aqueous reaction of the resultant carboxylate salt into the carboxylic acid to give 2-methyl-5-((2R,4S)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl) chroman-4-yl)benzoic acid (Compound A″), wherein the one or more hydroxide bases is selected from sodium hydroxide, lithium hydroxide, potassium hydroxide, cesium hydroxide, lithium chloride, and a combination thereof,

OG Complex Work Unit Chemistry